Feasibility Study of a Smartphone-Based Volunteer First Responder System Providing Naloxone Treatment for Suspected Opioid Overdoses
Led by Region Skane · Updated on 2025-12-17
1000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Opioid overdose causes significant global health problems, and while prevention and treatment programs exist, more efforts are needed to reduce deaths and complications. This research evaluates a novel smartphone-based volunteer first responder system integrated with national emergency call services to assist suspected opioid overdoses. The system aims to alert trained volunteers equipped with naloxone, an opioid antidote, to provide early treatment before emergency medical services arrive, potentially saving lives by reducing the time to naloxone administration.
Volunteer responders, called naloxone-responders, will complete training in opioid overdose recognition, naloxone use, and first aid based on European and Swedish guidelines. They will also learn low-arousal communication techniques for interacting with overdose victims. Each responder receives a kit with two doses of nasal naloxone and will be registered on a dedicated responder smartphone app. The study includes a two-year pilot phase with one-year follow-up per participant, along with multiple sub-studies examining feasibility, safety, acceptability, mortality, and experiences of responders and overdose survivors.
Participants will be monitored through questionnaires, app data, and medical records from dispatchers, paramedics, and hospitals. The primary outcomes include the number of successful naloxone responder alerts, responder acceptability, clinical outcomes of overdose victims, and safety experiences during alerts. Mortality rates before and after the trial will also be analyzed. The study runs from September 2025 to August 2027, assessing both short- and long-term effects of integrating volunteer responders with emergency medical dispatch.
CONDITIONS
Brief Title
A Model to Save Lives Through a Volunteer First Responder Service Providing Antidote Treatment in Opioid Overdose
Research Team
J
Julia Rehn, MD, PhD student
J
Josephine Hansson, Reg nurse, PM
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Give informed written consent to participate in the study
Successfully complete an opioid overdose and naloxone course plus a first aid course following current guidelines
Download and register as a user on the volunteer first responder smartphone app
Purchase naloxone from a pharmacy and submit the receipt for reimbursement
Overdose victim must be 15 years or older for alerts
Naloxone-responders must be within 10,000 meters of the overdose situation in Skåne
You will not qualify if you...
Display inappropriate behavior during the education or training sessions
Presence of trauma behind the overdose condition
Dispatcher assesses the scene as unsafe for lay persons
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for course completion and registration
Treatment
Duration - 12 months of active participation
Participants complete training courses on opioid overdose recognition, naloxone usage, and first aid, then become active volunteer responders equipped with naloxone and a smartphone app to respond to suspected opioid overdoses.
Ongoing use of the responder app and naloxone kit during the 12 months
Follow-up
Duration - 12 months post-participation follow-up
Participants and overdose victims are surveyed to assess safety, acceptability, and clinical outcomes during and up to 12 months after participation.
1 to 2 surveys after participation
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Testing a Combined Telehealth, Peer Support, and Buprenorphine Program to Improve Treatment After Opioid Overdose in Emergency Department Patients
Feasibility Study of a Smartphone-Based Volunteer First Responder System Providing Naloxone Treatment for Suspected Opioid Overdoses
Evaluating the UnityPhilly Overdose Response App for Preventing Opioid Overdoses and Supporting Community Safety in Philadelphia
Houston Emergency Response Opioid Engagement Program for Youths Aged 13 to 17
Combining Medication and Behavioral Support for Opioid Dependence
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The RESPONDER trial: a feasibility study of an early intervention model deploying community first responders to administer intranasal naloxone in suspected opioid overdoses in Skåne, Sweden.